Type II Pleuropulmonary Blastoma in a 4 Month Old Infant with Negative Dicer1 Mutation on Next Generation Sequencing

• Published in: Medicinski arhiv 2021, Vol.75 (1), p.61-65
• Main Authors: Spahiu, Lidvana, Gafurri, Zana, Uka, Violeta, Salihu, Shpetim, Maqastena, Rufadije, Behluli, Emir
• Format: Article
• Language: English
• Subjects: Biomarkers; Brain cancer; Cancer therapies; Case Report; Chemotherapy; Children & youth; Cysts; Disease; Families & family life; Gene expression; Histopathology; Hyperplasia; Leukopenia; Lungs; Medical imaging; Medical prognosis; Metastasis; Mutation; Patients; Pediatrics; Sarcoma; Sepsis; Surgery; Thyroid gland; Tumors; Ultrasonic imaging
• ISSN: 0350-199X; 1986-5961
• DOI: 10.5455/medarh.2021.75.61-65

Introduction: Pleuropulmonary blastoma (PPB) is a rare, but aggressive tumor in the pediatric population. PPB is a dysontogenetic neoplasm of childhood that involves the lungs and/or pleura. Young relatives of children with PPB have an increased incidence of neoplasias and dysplasias. According to tumor tissue histopathology, PPB evolves from a cystic to solid state over time. PPBs can be sub-classified as type I (purely cystic), type II (having both cystic and solid elements), and type III (completely solid). Type II and type III tumors may be associated with metastasis, with the brain being the most common metastatic site. Due to the primitive nature of cells in the tumor mass, PPBs are very aggressive tumors that are resistant to therapy. The prognosis depends on the histopathology content and tumor type. Respiratory problems are the main complaint and diagnosis can be made only after additional examinations. Genetic relations through family members are associated with mutations in the DICER1 gene; between 60-80% of patients with PPBs are positive for DICER1 mutations. Mosaicism has also been reported. Aim: The aim was to present a case of a 4 month-old infant with type II PPB, who had a negative result for DICER1 mutation in next generation sequencing. To detail the clinical presentation of this patient, we present radiographic and ultrasound findings and results of histopathological analysis, as well as genetic and scintigraphic findings and chemotherapy treatment. Case report: Here we describe the genetic analysis of a patient with PPB who was negative for mutations in DICER1 and who had no relatives with disease. This patient underwent radical resection of the tumor and began therapy, but subsequently died after developing leukopenia and sepsis. Conclusion: This case provides an example of a patient with PPB who was negative for DICER1 mutation upon genetic analysis and emphasizes the potential for disease that does not involve mutation of this gene.